Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-08-30Clinical Trial Update: Comparison of Insulin Glargine and NPH Insulin at Night and at Hypoglycemia in Type 2 Diabetes
A completed trial compared nighttime administration and hypoglycemia risk between insulin glargine and NPH insulin in people with type 2 dia…
-
CLINICAL_TRIALS trial_result · 2007-08-29Clinical Trial Update: Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition [Phase 4]
A Phase 4 clinical trial investigates whether achieving very low LDL cholesterol with statin therapy influences steroidogenesis and cognitiv…
-
CLINICAL_TRIALS trial_result · 2007-08-28Clinical Trial Update: C-Reactive Protein (CRP) in Obese Diabetic Women [Phase 4]
Phase 4 clinical trial update reporting completion of a study evaluating C-reactive protein in obese women with type 2 diabetes.
-
FDA approval · 2007-08-27FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2007-08-27Clinical Trial Update: Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk
Completed clinical trial evaluating screening for undiagnosed Type 2 diabetes mellitus in new classes of high-risk subjects; sponsor IRCCS S…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-08-23Clinical Trial Update: Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) [Phase 2]
The Phase 2 safety and efficacy trial of PN2034 in Type 2 Diabetes patients on rosiglitazone and metformin has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-23Clinical Trial Update: Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial evaluating PN2034 in insulin-dependent patients with Type 2 Diabetes Mellitus has completed.
-
FDA approval · 2007-08-23FDA Approved: GLIMEPIRIDE — Original Application (Accord Healthcare Inc)
FDA approved Accord Healthcare Inc.'s Original Application (ANDA) for a generic form of glimepiride. Glimepiride is used to treat type 2 dia…
-
FDA approval · 2007-08-22FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company (including the associated diluent).
-
FDA approval · 2007-08-22FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2007-08-22FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly. The approval covers changes under a supplemental submi…
-
FDA approval · 2007-08-22FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company to update the product's lab…
-
CLINICAL_TRIALS withdrawal · 2007-08-21Clinical Trial Update: Inflammatory Response and Pregnancy Outcome in Women With Type 2 Diabetes or Overweight [Phase 1]
A Phase 1 trial investigating inflammatory response and pregnancy outcomes in women with type 2 diabetes mellitus or overweight has been wit…
-
CLINICAL_TRIALS trial_result · 2007-08-16Clinical Trial Update: Exercise Training in Older Diabetic Women [Phase 1]
Phase 1 clinical trial evaluating exercise training in older women with Type 2 diabetes mellitus; cardiovascular disease is among the condit…
-
FDA approval · 2007-08-14FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ACTOS (pioglitazone) from Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2007-08-01Clinical Trial Update: Determining the Effect on Patients of Internet-Based Diabetes Disease Management [NA]
A completed clinical trial assessing the impact of internet-based diabetes disease management on patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2007-07-20Clinical Trial Update: Lifestyle Intervention in Primary Health Care - the Björknäs Study [Phase 3]
Phase 3 Björknäs Study evaluating a lifestyle intervention in primary health care has completed. The study targets hypertension and type 2 d…
-
CLINICAL_TRIALS trial_result · 2007-07-11Clinical Trial Update: Duodenal Jejunal Bypass for Type 2 Diabetes (DJBD) [Phase 1]
Phase 1 clinical trial update for the Duodenal Jejunal Bypass (DJBD) procedure in type 2 diabetes mellitus. The status is listed as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2007-06-28Clinical Trial Update: To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial comparing the efficacy and safety of vildagliptin versus voglibose in patients with type 2 diabetes has completed.
-
CLINICAL_TRIALS research · 2007-06-28Clinical Trial Update: A Study of Attitudes About the Risk of Developing Type 2 Diabetes [NA]
This completed study, sponsored by Eastern Virginia Medical School, surveyed attitudes about the risk of developing Type 2 Diabetes Mellitus…
-
CLINICAL_TRIALS trial_result · 2007-06-27Clinical Trial Update: Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin [Phase 3]
A Phase 3 trial evaluating a pre-filled insulin pen in Type 2 diabetes patients on twice-daily insulin reported complaints associated with i…
-
CLINICAL_TRIALS trial_result · 2007-06-25Clinical Trial Update: Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes [NA]
Clinical trial update evaluating the acute glycemic effects of a very low-fat diet in people with type 2 diabetes.
-
FDA approval · 2007-06-14FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2007-06-13FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for Metformin hydrochloride (generic) from Mylan Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2007-06-05Clinical Trial Update: Comparison Between Pioglitazone and SES With type2 DM [Phase 2, Phase 3]
Phase 2/3 clinical trial comparing pioglitazone to SES in patients with coronary artery disease and type 2 diabetes mellitus has completed. …